4.3 Article

Serotonin syndrome masquerading as disease flare in lupus nephritis with end-stage renal disease

Journal

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Volume 22, Issue 10, Pages 1933-1936

Publisher

WILEY
DOI: 10.1111/1756-185X.13683

Keywords

end-stage renal disease; linezolid; lupus nephritis; serotonin syndrome; serotonin toxicity

Categories

Ask authors/readers for more resources

Introduction Serotonin syndrome is a potentially life-threatening condition characterized by the triad of mental status changes, autonomic instability, and neuromuscular changes. We report a case of serotonin syndrome masquerading as disease flare in a lupus nephritis patient with end-stage renal disease receiving linezolid for the treatment of infected pseudoaneurysm. Case report A 36-year-old female lupus nephritis patient on maintenance hemodialysis for end-stage renal disease had been on multiple antibiotics, including anti-tuberculosis medications, over the past month for infected pseudoaneurysm complicating her arteriovenous fistula. Due to minimal response, she underwent pseudoaneurysmal ligation and given linezolid. Two days later, she developed chest pain, tachycardia, hypertension, tremors, later accompanied by high-grade fever, diarrhea, insomnia, and body weakness. Although fully awake and oriented, she was markedly agitated, mildly icteric, had hyperreflexia and asthenia with proximal muscle strength graded 3/5 in all extremities. Blood counts revealed anemia and thrombocytopenia; ancillary tests showed aspartate aminotransferase markedly higher than alanine aminotransferase, elevated serum lactate dehydrogenase and creatine kinase, and low C3 levels. Intravenous hydrocortisone was started for a suspected lupus flare. On the background of linezolid, isoniazid, and tramadol administration, serotonin syndrome with rhabdomyolysis was strongly considered. Offending drugs were discontinued, resulting in the dramatic improvement of symptoms and improved strength and well-being. The steroid was successfully tapered to 5 mg/day and a week later, she remained afebrile without recurrence of symptoms. Conclusion Serotonin syndrome should be considered in patients on multiple serotonergic agents on the background of end-stage renal disease. Prompt recognition and distinction from lupus activity can significantly impact management decisions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Biologic therapies in systemic lupus erythematosus

Christine B. Bernal, Leonid D. Zamora, Sandra V. Navarra

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2015)

Meeting Abstract Rheumatology

FREQUENCY AND PREDICTORS OF ATTAINMENT OF THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) IN A CROSS SECTIONAL STUDY OF SLE PATIENTS IN THE ASIA PACIFIC

V. Golder, R. Kandane-Rathnayake, A. Hoi, W. Louthrenoo, Y. An, Z. G. Li, S. F. Luo, S. Sockalingam, C. S. Lau, A. L. Lee, M. Y. T. Mok, A. Lateef, K. Franklyn, S. V. Navarra, L. Zamora, Y. -J. Wu, L. Hamijoyo, M. Chan, S. O'Neill, F. Goldblatt, M. Huq, M. Nikpour, E. F. Morand

ANNALS OF THE RHEUMATIC DISEASES (2016)

Article Rheumatology

Development of the Asia Pacific Lupus Collaboration cohort

Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, Shue-Fen Luo, Yeong-Jian Jan Wu, Zhanguo Li, Yuan An, Aisha Lateef, Sargunan Sockalingam, Sandra V. Navarra, Leonid Zamora, Laniyati Hamijoyo, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Sean O'Neill, Fiona Goldblatt, Yanjie Hao, Zhuoli Zhang, Jamal Al-Saleh, Munther Khamashta, Tsutomu Takeuchi, Yoshiya Tanaka, Sang-Cheol Bae, Chak Sing Lau, Alberta Hoi, Mandana Nikpour, Eric F. Morand

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)

Article Rheumatology

Lupus education for physicians and patients in a resource-limited setting

Sandra V. Navarra, Leonid D. Zamora, Ma. Theresa M. Collante

CLINICAL RHEUMATOLOGY (2020)

Article Rheumatology

Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus

Leonid D. Zamora, Ma. Theresa M. Collante, Sandra V. Navarra

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)

Article Rheumatology

Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study

Rangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, Yeong-Jian J. Wu, Yi-Hsing Chen, Vera Golder, Aisha Lateef, Jiacai Cho, Sandra Navarra, Leonid Zamora, Laniyati Hamijoyo, Sargunan Sockalingam, Yuan An, Zhanguo Li, Ricardo Montes, Shereen Oon, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Fiona Goldblatt, Sean O'Neill, Sang-Cheol Bae, Chak S. Lau, Alberta Hoi, Chetan S. Karyekar, Mandana Nikpour, Eric F. Morand

Summary: This study examined medication use patterns in systemic lupus erythematosus (SLE) using data from a large multicenter longitudinal cohort. The results showed that most patients received combination treatment, with high persistence for glucocorticoids (GCs) and low persistence for immunosuppressants (IS). Patients with higher disease activity received more medication combinations but had lower IS persistence.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Vera Golder, Rangi Kandane-Rathnayake, Alberta Yik-Bun Hoi, Molla Huq, Worawit Louthrenoo, Yuan An, Zhan Guo Li, Shue Fen Luo, Sargunan Sockalingam, Chak Sing Lau, Mo Yin Mok, Aisha Lateef, Kate Franklyn, Susan Morton, Sandra Teresa V. Navarra, Leonid Zamora, Yeong-Jian Wu, Laniyati Hamijoyo, Madelynn Chan, Sean O'Neill, Fiona Goldblatt, Mandana Nikpour, Eric Francis Morand

ARTHRITIS RESEARCH & THERAPY (2017)

No Data Available